TY - JOUR AU - Filloux, Francis M. PY - 2015 TI - Cannabinoids for pediatric epilepsy? Up in smoke or real science? JF - Translational Pediatrics; Vol 4, No 4 (October 31, 2015): Translational Pediatrics (Advancements in Pediatric Epilepsy Part I)<sup>1</sup> Y2 - 2015 KW - N2 - Public interest in the use of “medical marijuana” for the treatment of childhood epilepsy has burgeoned in the last few years. This has occurred in parallel with a growing interest in “medical marijuana” in general. Physicians and pediatricians must balance their patients’ desire for immediate access to these products with the tenets of evidence-based medicine. This review discusses the biochemistry of cannabis products (the phytocannabinoids ) setting this in the context of the endogenous endocannabinoid system. The differing and potentially modulating effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are reviewed. The evidence-base supporting or not the use of cannabis products for the treatment of neurological disease and specifically epilepsy is explored. The potential for adverse effects and particularly of neurotoxicity is addressed. Finally, public health and sociocultural implications are touched upon. Specific recommendations for interested physicians are provided including advocacy for patients and for a change in the “scheduling” of cannabis in order to better foster much-needed high-quality scientific research in this important area. UR - https://tp.amegroups.org/article/view/8122